Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Genet.

Sec. Genetics of Common and Rare Diseases

Genomic and Ancestral Variations linked to the Development of Post-Acute Sequelae of SARS-CoV-2 infection in Indian Populations

Provisionally accepted
  • 1Yenepoya Research Centre, Yenepoya University, Mangalore, India
  • 2Yenepoya Medical College Department of Community Medicine, Mangaluru, India
  • 3Durham University, Durham, United Kingdom
  • 4Kasturba Medical College Manipal, Manipal, India

The final, formatted version of the article will be published soon.

Background Susceptibility to infectious diseases is a result of complex interactions between genomic, environmental, and clinical factors. COVID-19 severity and post-acute sequelae of COVID-19 (PASC) vary widely among individuals, yet its genetic determinants remain underexplored in Indian populations. Here we undertake an exploratory analysis to investigate candidate genetic variants and biological pathways underlying the clinical outcomes in COVID-19 severity and PASC. Methods Sixty individuals with a history of COVID-19 were genotyped, and their data were supplemented with publicly available datasets from the Genome Asia 100K and Gujarat Biotechnology Research Centre. Two case-control genome-wide association study (GWAS) models were analysed: (i) COVID-19 severity (mild/asymptomatic vs severe), and (ii) an exploratory, hypothesis-generating GWAS for PASC (presence vs absence of post-COVID-19 complications). Candidate genes identified here were further compared with RNA sequencing datasets derived from brain and lung tissues of SARS-CoV-2-infected hamsters. Population-specific genetic risk for PASC was estimated using the polygenic risk score algorithm PRSice2. Results GWAS identified candidate genes common to both COVID-19 severity and PASC, including CNTNAP2, WWOX, and ADAMTS17, which are implicated in extracellular matrix remodelling, and neurological and cognitive development. We identified 806 candidate genes shared between the severity and PASC cohorts. Of these, 30 protein-coding genes were associated with neuropsychiatric disorders and 23 were linked to cardiovascular conditions. Notably, CACNA1C, SLC8A1, GRK5, PDE4B, and LRRK2 appeared in both categories, indicating potential convergence of molecular pathways underlying neurological and cardiovascular dysfunction. Integration with transcriptomic data reinforced the involvement of shared molecular pathways disrupted by SARS-CoV-2 infection. Polygenic risk analysis revealed significant population-specific variation in genetic predisposition to PASC. Conclusion Genetic susceptibility to severe COVID-19 and PASC in Indian populations appears linked to dysregulation of pathways central to cardiac and neurological function. These findings derived from an exploratory PASC GWAS provide preliminary insights into the molecular mechanisms that may underlie the post viral sequelae. These emphasize the need for population-wide genomic studies to validate the candidate associations, better understand PASC risk and facilitate the development of precision diagnostics and therapeutics.

Keywords: PASC, COVID-19 host-genetics, GWAS, genetic epidemiology, multiomics

Received: 04 Sep 2025; Accepted: 24 Nov 2025.

Copyright: © 2025 Shenoy, Udupa, A.I, Sunil, Sardarni, Kumar, Acharya, Byrareddy, Upadhyai and Das. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Siddappa N Byrareddy
Priyanka Upadhyai
Ranajit Das

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.